SCHEMBL16470964

SCHEMBL16470964

COc1ccccc1/C=C/C(=O)N=[N+]=[N-]

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NFE2L2 Q16236 2/20 0.62
▸ TFEB P19484 1/20 0.62
▸ KDM4E B2RXH2 2/20 0.60
▸ MAPT P10636 4/20 0.56
▸ NPC1 O15118 4/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ LMNA P02545 2/20 0.56
▸ BCHE P06276 1/20 0.56
▸ MAPK1 P28482 2/20 0.55
▸ ATM Q13315 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ LY96 Q9Y6Y9 1/20 0.54
▸ MAOB P27338 3/20 0.52
▸ AR P10275 1/20 0.52
▸ CYP1A2 P05177 4/20 0.51
▸ CYP2D6 P10635 4/20 0.51
▸ CYP1A1 P04798 3/20 0.51
▸ CYP1B1 Q16678 3/20 0.51
▸ CYP3A4 P08684 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13729042 0.83 CTSL (0.50) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL13729045 0.83 CTSL (0.50) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL28922419 0.80 BACE1 (0.52) NFE2L2TFEBKDM4EMAPTLMNA
SCHEMBL22241935 0.80 BACE1 (0.52) NFE2L2TFEBKDM4EMAPTLMNA
SCHEMBL5427616 0.78 NFE2L2 (0.64) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL2744047 0.77 NFE2L2 (1.00) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL16403662 0.77 NFE2L2 (1.00) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL30307386 0.77 NFE2L2 (1.00) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL2744044 0.77 NFE2L2 (1.00) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL29805195 0.77 NFE2L2 (1.00) NFE2L2TFEBKDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1684787-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-04-16 — — EP disclosed
WO-2005051410-A9 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2005-07-28 — — WO disclosed
WO-2005051410-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-06-09 — — WO disclosed
Send feedback